Objective: The authors sought to determine whether the administration of fl
umazenil would induce marked panic symptoms in women suffering from premens
trual dysphoric disorder.
Method: Ten women with premenstrual dysphoric disorder and 11 comparison su
bjects were injected with flumazenil or placebo in a double-blind, randomiz
ed, balanced crossover design in a single session in the luteal phase of th
eir menstrual cycles.
Results: Flumazenil induced a much greater panic response in the women with
premenstrual dysphoric disorder than in the comparison subjects.
Conclusions: These preliminary results are consistent with a dysregulation
of the gamma-aminobutyric acid A/benzodiazepine receptor complex during the
premenstruum of women suffering from premenstrual dysphoric disorder.